Ritter Pharmaceuticals (RTTR) Short Interest Ratio & Short Volume

Short interest is the volume of Ritter Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 902,900 shares of RTTR short. Learn More on Ritter Pharmaceuticals' current short interest.

Ritter Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 902,900 shares, an increase of 19.7% from the previous total of 754,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Ritter Pharmaceuticals: Edesa Biotech, Inc. (0.83%), Kiora Pharmaceuticals, Inc. (0.71%), VBI Vaccines Inc. (1.30%), Imunon, Inc. (4.75%), Cocrystal Pharma, Inc. (0.07%), Monopar Therapeutics Inc. (2.29%), Tonix Pharmaceuticals Holding Corp. (1.48%), Benitec Biopharma Inc. (0.47%), ABVC BioPharma, Inc. (15.21%), Orgenesis Inc. (0.87%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($7.01 billion), Charter Communications, Inc. ($4.31 billion), Match Group, Inc. ($2.95 billion), The Charles Schwab Co. ($2.81 billion), Tesla, Inc. ($2.69 billion), Microchip Technology Incorporated ($2.59 billion), Wayfair Inc. ($2.19 billion), Snap Inc. ($1.99 billion), The Clorox Company ($1.97 billion), and International Flavors & Fragrances Inc. ($1.92 billion). View all of the most shorted stocks.

Short selling RTTR is an investing strategy that aims to generate trading profit from Ritter Pharmaceuticals as its price is falling. RTTR shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Ritter Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RTTR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RTTR, twice per month. The most recent reporting period available is April, 30 2020.